ARK Genomic Revolution ETF (ARKG): ETF
ETF traded on BATS under symbol ARKG. Quoted in usd.
ARK Genomic Revolution ETF
+6.01%$51.65
Pre-Market$51.90+0.48%
BATS:ARKGEquity
AUM $2.22B·YTD --·Yield --
BATS:ARKG$51.65+6.01%AUM $2.22BAbout ARKG
The ARKG fund operates as an actively managed Exchange Traded Fund (ETF), aiming to achieve significant capital appreciation over an extended period. Its investment strategy involves committing a minimum of 80% of its total assets, under typical market conditions, to equity securities issued by both domestic and international companies. These companies are strategically chosen from various sectors based on their direct connection to the fund's core investment principle: the groundbreaking genomics revolution.
Largest holdings
- TXG 10X GENOMICS INC-CLASS A8.82%
- TWST TWIST BIOSCIENCE CORP8.27%
- TEM TEMPUS AI INC-CL A8.15%
- CRSP CRISPR THERAPEUTICS AG5.32%
- GH GUARDANT HEALTH INC5.16%
- ILMN ILLUMINA INC4.95%
- NTRA NATERA INC4.94%
- ABSI ABSCI CORP4.90%
- LLY ELI LILLY & CO4.13%
- CDNA CAREDX INC3.82%
Dividend History
Benchmark Comparison
Compared against
Performance Returns
Drawdown Chart
Analyst Coverage
Savings Plan Calculator
Total Invested
$70,000
Final Portfolio
$108,346
Total Return
+$38,346
(+54.8%)
Dividends Reinvested
$0
compounded into portfolio
Defaults are seeded from historical performance and trailing twelve-month yield. Past performance is not a forecast. Feel free to adjust any input to model your own assumptions.
ETF Key Metrics
AUM$2.22B
NAV$48.74
Premium/Discount+5.97%
Expense Ratio0.75%
Market Cap--
Shares Outstanding--
Inception DateOct. 31, 2014
Fund Details
52-Week Range
$20.26$34.39
Current: $51.65
Volume
Volume6.01M
Avg Volume4.21M
Vol/Avg1.43x
30d
5.62M
60d
4.77M
90d
4.45M
Comparable ETFs